These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8019139)

  • 1. Three-dimensional structure of echistatin and dynamics of the active site.
    Chen Y; Suri AK; Kominos D; Sanyal G; Naylor AM; Pitzenberger SM; Garsky VM; Levy RM; Baum J
    J Biomol NMR; 1994 May; 4(3):307-24. PubMed ID: 8019139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional structure of echistatin, the smallest active RGD protein.
    Saudek V; Atkinson RA; Pelton JT
    Biochemistry; 1991 Jul; 30(30):7369-72. PubMed ID: 1854743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton NMR assignments and secondary structure of the snake venom protein echistatin.
    Chen Y; Pitzenberger SM; Garsky VM; Lumma PK; Sanyal G; Baum J
    Biochemistry; 1991 Dec; 30(50):11625-36. PubMed ID: 1661142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echistatin: the refined structure of a disintegrin in solution by 1H NMR and restrained molecular dynamics.
    Atkinson RA; Saudek V; Pelton JT
    Int J Pept Protein Res; 1994 Jun; 43(6):563-72. PubMed ID: 7928087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H NMR studies of echistatin in solution. Sequential resonance assignments and secondary structure.
    Dalvit C; Widmer H; Bovermann G; Breckenridge R; Metternich R
    Eur J Biochem; 1991 Dec; 202(2):315-21. PubMed ID: 1761035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear magnetic resonance studies of the snake toxin echistatin. 1H resonance assignments and secondary structure.
    Cooke RM; Carter BG; Martin DM; Murray-Rust P; Weir MP
    Eur J Biochem; 1991 Dec; 202(2):323-8. PubMed ID: 1761036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H-NMR studies and secondary structure of the RGD-containing snake toxin, albolabrin.
    Jaseja M; Smith KJ; Lu X; Williams JA; Trayer H; Trayer IP; Hyde EI
    Eur J Biochem; 1993 Dec; 218(3):853-60. PubMed ID: 8281937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Site-directed mutagenesis of the gene of Echistatin Leu14-Lys15-Glu16].
    Li H; Li X; Hu M
    Yi Chuan Xue Bao; 1996; 23(2):163-8. PubMed ID: 8695184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR solution structure of the non-RGD disintegrin obtustatin.
    Paz Moreno-Murciano M; Monleón D; Marcinkiewicz C; Calvete JJ; Celda B
    J Mol Biol; 2003 May; 329(1):135-45. PubMed ID: 12742023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nuclear magnetic resonance solution structure of flavoridin, an antagonist of the platelet GP IIb-IIIa receptor.
    Senn H; Klaus W
    J Mol Biol; 1993 Aug; 232(3):907-25. PubMed ID: 8355277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The secondary structure of echistatin from 1H-NMR, circular-dichroism and Raman spectroscopy.
    Saudek V; Atkinson RA; Lepage P; Pelton JT
    Eur J Biochem; 1991 Dec; 202(2):329-38. PubMed ID: 1761037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins.
    McLane MA; Vijay-Kumar S; Marcinkiewicz C; Calvete JJ; Niewiarowski S
    FEBS Lett; 1996 Aug; 391(1-2):139-43. PubMed ID: 8706902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The solution structure of echistatin: evidence for disulphide bond rearrangement in homologous snake toxins.
    Cooke RM; Carter BG; Murray-Rust P; Hartshorn MJ; Herzyk P; Hubbard RE
    Protein Eng; 1992 Sep; 5(6):473-7. PubMed ID: 1438157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational studies of the 'RGD' containing peptide echistatin and close analogs by circular dichroism and fluorescence.
    Brockel C; Cowley DJ; Pelton JT
    Biochim Biophys Acta; 1992 Jul; 1122(2):196-202. PubMed ID: 1643093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution conformation of a model hexapeptide containing RGD sequence.
    Dhingra MM
    Indian J Biochem Biophys; 1992 Dec; 29(6):458-64. PubMed ID: 1294461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis of a biologically active echistatin analogue des(46-49)-[Ala8,37]-echistatin gamma with three disulfide bonds by 2D-NMR and computer graphics.
    Chuang LC; Chen PY; Chen C; Huang TH; Wang KT; Chiou SH; Wu SH
    Biochem Biophys Res Commun; 1996 Mar; 220(2):246-54. PubMed ID: 8645291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity studies of the s-echistatin inhibition of bone resorption.
    Sato M; Garsky V; Majeska RJ; Einhorn TA; Murray J; Tashjian AH; Gould RJ
    J Bone Miner Res; 1994 Sep; 9(9):1441-9. PubMed ID: 7817829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the structure of two novel echistatin variants and comparison of the ability of echistatin variants to inhibit aggregation of platelets from different species.
    Chen YL; Huang TF; Chen SW; Tsai IH
    Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):513-20. PubMed ID: 7832768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformation and concerted dynamics of the integrin-binding site and the C-terminal region of echistatin revealed by homonuclear NMR.
    Monleón D; Esteve V; Kovacs H; Calvete JJ; Celda B
    Biochem J; 2005 Apr; 387(Pt 1):57-66. PubMed ID: 15535803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogs.
    Garsky VM; Lumma PK; Freidinger RM; Pitzenberger SM; Randall WC; Veber DF; Gould RJ; Friedman PA
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4022-6. PubMed ID: 2726764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.